www.ajmc.com Open in urlscan Pro
76.76.21.9  Public Scan

Form analysis
2 forms found in the DOM

<form class="form-inline"><input type="text" placeholder="Search" value="" class="form-control"><button style="background-color:var(--secondary);border:none" type="button" class="btn btn-primary">Search</button></form>

<form class="form-inline"><input type="text" placeholder="Search" value="" class="form-control"><button style="background-color:var(--secondary);border:none" type="button" class="btn btn-primary">Search</button></form>

Text Content

 * 
 * 

Search
Stakeholders
View MoreAcademiaEmployersHealth SystemPayersProviders
AcademiaEmployersHealth SystemPayersProviders
Topics
View MoreClinicalHealth Care CostHealth Care
DeliveryInsurancePolicyTechnologyValue-Based Care
ClinicalHealth Care CostHealth Care DeliveryInsurancePolicyTechnologyValue-Based
Care
Institute for Value-Based Medicine
View MoreAll CoverageEvent CoverageInterviewsNews
All CoverageEvent CoverageInterviewsNews
About AJMC
AJMC JournalsAnniversaryAuthor FormsAuthorsNominate a Rising Leader
AJMC JournalsAnniversaryAuthor FormsAuthorsNominate a Rising Leader
News
All News
Partners
Press Releases
Product Approvals and Launches
All NewsPartnersPress ReleasesProduct Approvals and Launches
Media
Clinical Spotlight
Enduring Webinars
Guidelines
Insights
Interviews
Medical World News
Microsites
News Network
OnLocation
Peer Exchange
Podcasts
Post Conference Perspectives
Sponsored
Stakeholder Summit
Week in Review
Clinical SpotlightEnduring WebinarsGuidelinesInsightsInterviewsMedical World
NewsMicrositesNews NetworkOnLocationPeer ExchangePodcastsPost Conference
PerspectivesSponsoredStakeholder SummitWeek in Review
Conferences
Conference Coverage
Conference Listing
Conference CoverageConference Listing
Journals
All Journals
The American Journal of Managed Care
The American Journal of Accountable Care
Evidence-Based Oncology
Evidence-Based Diabetes Management
Supplements and Featured Publications
All JournalsThe American Journal of Managed CareThe American Journal of
Accountable CareEvidence-Based OncologyEvidence-Based Diabetes
ManagementSupplements and Featured Publications
Compendia
Asthma
At-Home Assessments
Atopic Dermatitis
Automated Insulin Delivery
Biosimilars
Breast Cancer
Cholangiocarcinoma
Chronic Kidney Disease
Comprehensive Genomic Profiling
COPD
Dermatology
Diabetes
Employers
Eosinophilic Esophagitis (EoE)
Heart Failure
Hematology
Hemophilia
HIV
Immuno-Oncology
Infectious Disease
Leukemia and Lymphoma
Liver
Lung Cancer
Lupus
Major Depressive Disorder
Medicare
Multiple Myeloma
Nasal Polyps
Oncology
Ophthalmology
Parkinson Disease
Prescription Digital Therapeutics
Psoriasis
Pulmonary Arterial Hypertension
Rare Blood
Rare Disease
Respiratory
Rheumatology
Skin Cancer
Sleep
Spinal Muscular Atrophy
Type 1 Diabetes
AsthmaAt-Home AssessmentsAtopic DermatitisAutomated Insulin
DeliveryBiosimilarsBreast CancerCholangiocarcinomaChronic Kidney
DiseaseComprehensive Genomic
ProfilingCOPDDermatologyDiabetesEmployersEosinophilic Esophagitis (EoE)Heart
FailureHematologyHemophiliaHIVImmuno-OncologyInfectious DiseaseLeukemia and
LymphomaLiverLung CancerLupusMajor Depressive DisorderMedicareMultiple
MyelomaNasal PolypsOncologyOphthalmologyParkinson DiseasePrescription Digital
TherapeuticsPsoriasisPulmonary Arterial HypertensionRare BloodRare
DiseaseRespiratoryRheumatologySkin CancerSleepSpinal Muscular AtrophyType 1
Diabetes
Events
Events
Upcoming Webinars
EventsUpcoming Webinars
CME/CE
Resources
Exclusive Content
Formulary Central
Interactive Tools
Exclusive ContentFormulary CentralInteractive Tools
Subscribe
eNewsletter
eNewsletter
 * About Us
 * Contact
 * Editorial Staff
 * Editorial Boards
 * Advertise
 * Do Not Sell My Information
 * Terms & Conditions
 * Privacy Policy

 * 

© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert
Insights. All rights reserved.

Search

Stakeholders
 * Academia
 * Employers
 * Health System
 * Payers
 * Providers

Topics
 * Clinical
 * Health Care Cost
 * Health Care Delivery
 * Insurance
 * Policy
 * Technology
 * Value-Based Care

Institute for Value-Based Medicine
 * All Coverage
 * Event Coverage
 * Interviews
 * News

About AJMC
 * AJMC Journals
 * Anniversary
 * Author Forms
 * Authors
 * Nominate a Rising Leader


 * About Us
 * Contact
 * Editorial Staff
 * Editorial Boards
 * Advertise
 * Do Not Sell My Information
 * Terms & Conditions
 * Privacy Policy
 * 

 * 

© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All
rights reserved.


FAIR HEALTH RELEASES REPORT ON SUBSTANCE USE DISORDERS, OVERDOSES BEFORE, DURING
PANDEMIC

September 27, 2022
Robin Gelburd, JD






One of the key findings of the report is that 42 states saw an increase in the
proportion of patients with opioid and opioid-like drug overdoses compared with
the total number of patients using medical services by state.



In every year of the period 2016-2021, males accounted for 62% to 63% of the
gender distribution of patients with a substance use disorder diagnosis, while
females made up 37% to 38%, according to a new white paper from FAIR Health.



In every year of the same period, females accounted for 60% to 61% of the gender
distribution of patients with an overdose diagnosis, while males made up 39% to
40%. The white paper, released Tuesday, is entitled A Comparison of Substance
Use Disorders before and during the COVID-19 Pandemic: A Study of Private
Healthcare Claims.



In this report, drawing on the nation’s largest repository of private healthcare
claims, FAIR Health analyzes substance use disorders and overdoses prior to the
COVID-19 pandemic as compared with during the pandemic. Trends in the percentage
of patients with a substance use disorder or overdose diagnosis are analyzed, as
well as such aspects as age, gender, incidence, relevant substances, states,
preexisting mental health conditions, venues of care and provider specialties.



Among the key findings:



From 2019 to 2021, 42 states saw an increase in the proportion of patients with
opioid and opioid-like drug overdoses compared with the total number of patients
using medical services by state. The increases ranged from 148.4% in
Pennsylvania to 0.7% in Minnesota.



During the pandemic, the percentage of patients with a substance use disorder
diagnosis decreased by 4.4%, from 3.5% of all patients in 2019 (pre-pandemic) to
3.4% in 2021 (during the pandemic). But in one age group, those 65 and older,
the percentage of patients with a substance use disorder diagnosis increased
5.3%, from 3.3% of all patients in that age group in 2019 to 3.5% in 2021.



The percentage of patients with an overdose diagnosis increased 4.3%, from 0.56%
of all patients in 2019 to 0.59% in 2021 (FIGURE 1).



FIGURE 1. Percent of Patients With an Overdose Diagnosis, 2016-2021

Credit: FAIR Health



Alcohol and opioids were the top 2 substances associated with substance use
disorders throughout the 2019-2021 time frame. Substance use disorders involving
alcohol, however, increased over that period from 47% to 52% of the
distribution, while opioids fell from 25% of the distribution to 21%.



From 2016 to 2021, the share of patients with substance use disorders involving
the use of stimulants (eg, amphetamines, methamphetamines) rose 36.4%, from
0.046% of all patients to 0.063%; this percentage increase exceeded those of
alcohol, opioids and cannabis.



In 2021, the percentage of patients with an initial diagnosis of substance use
disorder or overdose increased month over month compared with the 2 prior years.



In 2019 and 2021, New Mexico was the state with the highest proportion of
patients with a substance use disorder or overdose diagnosis.



From 2019 to 2021, Nebraska was the state with the greatest increase in the
proportion of patients with a substance use disorder diagnosis. Maryland was the
state with the greatest increase in the proportion of patients with
an overdose diagnosis.



Sixty-five percent of patients who had a substance use disorder or overdose
diagnosis in 2021 had a preexisting mental health condition. Generalized anxiety
disorder and major depressive disorder, in that order, were the 2 most common
mental health diagnoses in this population in 2021.



The percentage of substance use disorder services rendered via telehealth rose
from 0.3% in 2019 to 11.3 percent in 2020, then dropped to 9.3 percent in 2021
(FIGURE 2).



FIGURE 2. Distribution of Substance Use Disorder Claim Lines by Venue of Care,
2019-2021



Credit: FAIR Health





Psychiatrists’ share of substance use disorder claim lines increased 112.4%,
from 3.9% in 2016 to 8.3% in 2021.



This study is the latest in a series of FAIR Health studies on the COVID-19
pandemic. The new study also builds upon a series of white papers released by
FAIR Health involving substance use disorders, specifically opioid abuse and
dependence. Previous entries in that series include:

 * The Opioid Crisis among the Privately Insured
 * The Impact of the Opioid Crisis on the Healthcare System
 * Peeling Back the Curtain on Regional Variation in the Opioid Crisis
 * Opioid Abuse and Dependence

For the new white paper, click here.










--------------------------------------------------------------------------------